Provenance du réseau au premier degré de Nathalie Lemarié
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
21
| Public Company | Pharmaceuticals: Generic | 21 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Nathalie Lemarié via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| AMERICAN PACIFIC CORPORATION | Chemicals: Major Diversified | Director/Board Member | |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Healthcare Businesswomens Association
 Healthcare Businesswomens Association Miscellaneous Commercial ServicesCommercial Services Healthcare Businesswomens Association operates women healthcare associations. The company was founded by Diane Anderson, Peg Dougherty, Millicent Gryczka, Sheila Sinkking and Ruth Smith in 1977 and is headquartered in Fairfield, NJ. | Miscellaneous Commercial Services | Director/Board Member | |
| SHIRE | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| SILENCE THERAPEUTICS PLC | Miscellaneous Commercial Services | Chief Executive Officer | |
| VALERIO THERAPEUTICS | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chairman | |
Taconic Biosciences, Inc.
 Taconic Biosciences, Inc. Agricultural Commodities/MillingProcess Industries Taconic Biosciences, Inc. provides research rodents and related products and services. It offers monoclonal antibody production, drug safety testing and other services. The firm also provides contract breeding solutions, animal models, Taconic transgenic exchange, custom model generation, contract research solutions, and research services. The company was founded by Robert K. Phelan in 1949 and is headquartered in Rensselaer, NY. | Agricultural Commodities/Milling | Director/Board Member | |
Synt:em SA
 Synt:em SA Pharmaceuticals: MajorHealth Technology Synt:em SA researches and manufactures drugs for the treatment of pain and cancer. The company specializes in the discovery and development of Central Nervous System (CNS) medicines and novel therapeutics for the treatment diseases. It was founded in 1995 by Michel Kaczorek and Caroline Roussel and is headquartered in Nîmes, France. | Pharmaceuticals: Major | Corporate Officer/Principal Founder Corporate Officer/Principal | |
| Middlebury College | College/University | Undergraduate Degree | |
| INSEAD | College/University | Masters Business Admin Masters Business Admin | |
| METABOLIC EXPLORER | Chemicals: Specialty | Director of Finance/CFO Director/Board Member | |
ADEMTECH SA
 ADEMTECH SA Miscellaneous Commercial ServicesCommercial Services ADEMTECH SA specializes in developing and manufacturing magnetic nanoparticles for diagnostic and scientific research applications. The firm produces magnetic nanoparticles for concentration, separation, purification, microfluidic device integration and identification of molecules and specific cells. The company was founded in 2000 and is headquartered in Pessac, France. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member | |
| SUPERSONIC IMAGINE | Medical Specialties | Director/Board Member Director/Board Member | |
BPIFrance Investissement SAS
 BPIFrance Investissement SAS Investment ManagersFinance BPIFrance Investissement SAS (BPIfrance Investissement) is the private equity arm and subsidiary of State-owned Banque Publique d'Investissement in France. Formerly known as CDC Entreprises SAS, the firm was established in 1994 to carry out public-interest missions such as employment creation and momentum initiation in the private equity field. In 2013 they became BPIfrance Investissement when CDC Entreprises, FSI and FSI Régions merged. Headquartered in Paris, BPIfrance Investissement invests of behalf of the Government of France, as well as for third parties including FEI-Fonds Européen d'Investissement, BEI-Banque Européenne d'Investissement and BPCE SA. The firm invests directly or indirectly in SMEs and intermediate-sized companies at all stages of their development. | Investment Managers | Private Equity Investor Private Equity Analyst | |
| TXCELL | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member | |
Critical Care Diagnostics, Inc.
 Critical Care Diagnostics, Inc. Medical SpecialtiesHealth Technology Critical Care Diagnostics, Inc. develops diagnostic tools. The firm offers Presage, a laboratory assay employing ST2 for the diagnosis and prognosis of cardiovascular disease. It also offers Aspect-PLUS ST2 test, a cardiac biomarker testing product that aids clinicians in assessing risk, making treatment decisions, evaluating therapy effectiveness, and monitoring patient care. The company was founded by Sven M. Jacobson and David M. Geliebter in 2004 and is headquartered in San Diego, CA. | Medical Specialties | Chief Tech/Sci/R&D Officer | |
Remedy Pharmaceuticals, Inc.
 Remedy Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Remedy Pharmaceuticals, Inc. develops and commercializes pharmaceutical ingridients. It focuses on small molecule drugs for acute central nervous system disorders. The company was founded by David M. Geliebter and Sven M. Jacobson in 2004 and is headquartered in New York, NY. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Sibley & Associates, Inc.
 Sibley & Associates, Inc. Services to the Health IndustryHealth Services Whether its clients are an insurer, employer, or government organization, Sibley is their best connection to a single source solution to their disability issues. Through connected thinking, it provides fully-integrated solutions to prevent, manage and resolve client injury or illness no matter where their disability issues fall along the healthcare continuum. The company put all the pieces together. | Services to the Health Industry | President | |
HRA Pharma Development SARL
 HRA Pharma Development SARL Pharmaceuticals: MajorHealth Technology HRA Pharma Development SARL develops medicines and products for women's health and endocrinology. It offers emergency contraception, uterine fibroids, regular contraception, intimate health, genital herpes, and Lysosafe service. The company was founded by André Ulmann in 1996 and is headquartered in Châtillon, France. | Pharmaceuticals: Major | Director/Board Member Founder | |
| The French Society of Financial Analysts | College/University | Corporate Officer/Principal Director/Board Member | |
| PHARNEXT SCA | Biotechnology | Chief Executive Officer | |
| Weill Cornell Medical College | College/University | Doctorate Degree | |
International Association for the Study of Pain
 International Association for the Study of Pain Miscellaneous Commercial ServicesCommercial Services International Association for the Study of Pain operates as a professional forum for science, practice, and education in the field of pain. It brings together scientists, clinicians, health-care providers, and policymakers to stimulate and support the study of pain. The company was founded in 1973 and is headquartered in Washington, DC. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Laboratoire HRA-Pharma SA
 Laboratoire HRA-Pharma SA Pharmaceuticals: MajorHealth Technology Laboratoire HRA Pharma SA manufactures and distributes pharmaceutical products. Its products include contraceptive pills such as the pill of two days later and EllaOne. The company was founded by Andre Ulmann in 1996 and is headquartered in Paris, France. | Pharmaceuticals: Major | Founder | |
| ASARINA PHARMA AB | Pharmaceuticals: Major | Director/Board Member | |
| The University of Chicago Booth School of Business | College/University | Masters Business Admin | |
GamaMabs Pharma SA
 GamaMabs Pharma SA Medical/Nursing ServicesHealth Services GamaMabs Pharma SA specializes in developing monoclonal antibodies. It offers research and development solutions for biopharmaceutical industry. The company was founded by Jean-Francois Prost and Stephane Degove in June 2013 and is headquartered in Toulouse, France. | Medical/Nursing Services | Director/Board Member Director/Board Member Director/Board Member | |
| Marketing Research Institute International | President | ||
| Société Française d'Etude et de Traitement de la Douleur | Corporate Officer/Principal | ||
| International League Against Epilepsy | Corporate Officer/Principal | ||
CorWave SA
 CorWave SA Medical SpecialtiesHealth Technology CorWave SA develops and manufactures blood pumps. The company was founded in 2011 and is headquartered in Paris, France. | Medical Specialties | Director/Board Member Director/Board Member | |
| AKARI THERAPEUTICS, PLC | Biotechnology | Chief Executive Officer | |
| The Cass Foundation | Director/Board Member | ||
Sund Capital ApS
 Sund Capital ApS Financial ConglomeratesFinance Sund Capital ApS provides investment services. The private company is based in Copenhagen, Denmark. | Financial Conglomerates | Chief Executive Officer | |
LimFlow SA
 LimFlow SA Medical SpecialtiesHealth Technology LimFlow SA develops and offers medical devices which transformes the treatment of critical limb Ischemi. The firm?s proprietary and CE marked technology is a novel and purely percutaneous therapy for ?no-option? CLI patients. The company was founded by Martin T. Rothman in 2012 and is headquartered in Paris, France. | Medical Specialties | Director/Board Member Director/Board Member | |
Cemag SAS
 Cemag SAS Miscellaneous Commercial ServicesCommercial Services Cemag SAS is a French company that specializes in research and development of physical and natural sciences. The private company is based in Paris, France. | Miscellaneous Commercial Services | Chairman | |
| Cemag Consulting | Chief Executive Officer | ||
Silence Therapeutics GmbH
 Silence Therapeutics GmbH BiotechnologyHealth Technology Part of Silence Therapeutics Plc, Silence Therapeutics GmbH is a German biotechnology company that develops RNAi-based drugs. The private company is based in Berlin, Germany and was founded in 2014. | Biotechnology | Chief Executive Officer | |
| NH THERAGUIX SAS | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Ixaka Ltd.
 Ixaka Ltd. BiotechnologyHealth Technology Ixaka Ltd. engages in the development of advanced cell-based therapeutics for the treatment of critical limb ischemia. The company was founded by Gaby Salem and Vicente Saez Gonzalez in 2015 and is headquartered in London, the United Kingdom. | Biotechnology | Chairman | |
| Fort Hill Cos. Llc | Director/Board Member | ||
| Cemag-Care SA | Founder | ||
| Physip SA | Director/Board Member |
Statistiques
Internationale
| France | 23 |
| Etats-Unis | 18 |
| Royaume-Uni | 5 |
| Irlande | 2 |
| Canada | 2 |
Sectorielle
| Health Technology | 22 |
| Commercial Services | 8 |
| Consumer Services | 6 |
| Process Industries | 4 |
| Finance | 4 |
Opérationnelle
| Director/Board Member | 97 |
| Corporate Officer/Principal | 37 |
| Chairman | 21 |
| Chief Executive Officer | 18 |
| Undergraduate Degree | 17 |
Relations les plus connectées
| Insiders | |
|---|---|
| Philippe Boucheron | 24 |
| Jean-Michel Petit | 24 |
| Catherine Dunand | 23 |
| David Solomon | 22 |
| Thibaut Roulon | 18 |
| Paul Michalet | 16 |
| Charlotte Sibley | 13 |
| Julie Rachline | 13 |
| Luc-André Granier | 12 |
| André Ulmann | 11 |
| Hege Hellstrom | 11 |
| Didier Laurens | 8 |
| Catherine Guittet | 7 |
| Françoise Brunner-Ferber | 6 |
| Ludovic Robin | 6 |
- Bourse
- Insiders
- Nathalie Lemarié
- Connexions Sociétés
